Company news
Optibiotix Health Plc (LSE:OPTI) news
Optibiotix Health Plc news releases on 6ix. Latest, May 22, 2018: LP-LDL agreement for USA
Press releases — page 5
LP-LDL agreement for USA
May 22, 2018
SlimBiome® wins award at Vitafoods 2018
May 18, 2018
Exclusive manufacturing and supply agreement
May 16, 2018
Launch of extended range of products at Vitafoods
May 8, 2018
LP-LDL? news media interest in USA
May 1, 2018
Notice of Results
April 30, 2018
SlimBiome non-exclusive UK distribution agreement
April 24, 2018
Appointment of Head of Online Sales and Marketing
April 19, 2018
CholBiome exclusive distribution agreement
April 18, 2018
New patent filings for SweetBiotix
April 5, 2018
Scientific and commerical update
March 27, 2018
Launch of Slimbiome in Nutri-bites
March 8, 2018
LPLDL® Exclusive European License Agreement
March 6, 2018
OptiBiotix Capital Reorganisation
February 28, 2018
Exercise of warrant and issue of equity
February 6, 2018
Result of Meeting
January 25, 2018
SweetBiotix® development: human taste studies
January 23, 2018
Presentation of data at European Conference
January 17, 2018
Shareholder Circular and Notice of General Meeting
January 8, 2018
Manufacturing, supply & profit sharing agreement
December 12, 2017
Proposed directorate changes
December 5, 2017
Capital reorganisation
November 28, 2017
Exercise of Warrant and Issue of Equity
November 17, 2017
SlimBiome® commercial & product development update
November 8, 2017
Presentation of research
October 26, 2017
LPLDL® supply agreement with Galenicum
October 24, 2017
Successful launch of products at Supply Side West
October 4, 2017
Technical, regulatory & commercial update
September 19, 2017
Strategic partnership with Bened Biomedical
September 13, 2017
Invited to present at Expoquimia in Barcelona
September 7, 2017
Manufacturing Agreement with Tata Chemicals
September 5, 2017
US product launch of LPLDL® at trade show
August 24, 2017
Global manufacturing & supply agreement with Sacco
August 22, 2017
Market launch for LPLDL® capsules in Germany
July 26, 2017
Supply agreement with Pharmabiota Ltd
July 17, 2017
SweetBiotix® development: Results of taste study
July 11, 2017
Supply agreement with HLH Biopharma GmbH
June 15, 2017
Successful launch of LPLDL and SlimBiome products
May 16, 2017
LPLDL® Non-Exclusive European License Agreement
May 9, 2017
Presentation of abstract at conference
May 3, 2017
First German sales
April 25, 2017
UK Investor Show attendance
March 29, 2017
Intention to float SkinBiotherapeutics
March 21, 2017
Confirmation of Director appointments to the Board
March 15, 2017
European agreement with Sacco Srl
March 8, 2017
Launch of products at Vitafoods 2017
March 1, 2017
Result of General Meeting
January 26, 2017
Presentation of research data
January 24, 2017
Appointment of Sales and Marketing Director
January 18, 2017
Exercise of Option and Issue of Equity
January 13, 2017